Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients

Clinical trial NCT03084952 · UNKNOWN

Trial details

NCT number: NCT03084952
Sponsor: Infan Industria Quimica Farmaceutica Nacional
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Leishmaniasis; American, Cutaneous Drug Side Effect

Start date: 2021-05-01
Primary completion: 2023-12-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.